Literature DB >> 19808529

Additional value of myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of coronary artery disease.

Rolf Gebker1, Cosima Jahnke, Robert Manka, Ashraf Hamdan, Bernhard Schnackenburg, Eckart Fleck, Ingo Paetsch.   

Abstract

BACKGROUND: Dobutamine stress magnetic resonance (DSMR) imaging has emerged as a valuable tool for the detection of inducible wall motion abnormalities. The role of perfusion imaging during DSMR is not well defined. We examined whether the addition of myocardial perfusion imaging during DSMR provides incremental benefit for the evaluation of coronary artery disease. METHODS AND
RESULTS: DSMR was combined with perfusion imaging in 455 consecutive patients who were scheduled for clinically indicated invasive coronary angiography. Perfusion images were acquired in 3 standard short-views at rest and during maximum dobutamine-atropine stress. Wall motion and perfusion images were interpreted sequentially, blinded to other data. Significant (> or =70%) stenoses were present in 285 patients on invasive coronary angiography. The use of DSMR combined with perfusion imaging versus DSMR increased sensitivity (91% versus 85%, P=0.001), but not specificity (70% versus 82%, P=0.001), resulting in identical overall diagnostic accuracy (84% versus 84%, P=NS; Youden index 0.61 versus 0.67). DSMR combined with perfusion imaging enabled the correct diagnosis of coronary artery disease in an additional 13% of DSMR-negative patients at the cost of 11% more false-positive cases.
CONCLUSIONS: The addition of perfusion imaging during DSMR improves sensitivity for the diagnosis of coronary artery disease but does not enhance overall diagnostic accuracy because of a concomitant decrease in specificity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19808529     DOI: 10.1161/CIRCIMAGING.108.779108

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  24 in total

1.  Value of additional myocardial perfusion imaging during dobutamine stress magnetic resonance for the assessment of intermediate coronary artery disease.

Authors:  Rolf Gebker; M Frick; C Jahnke; A Berger; C Schneeweis; R Manka; S Kelle; C Klein; B Schnackenburg; E Fleck; I Paetsch
Journal:  Int J Cardiovasc Imaging       Date:  2010-12-14       Impact factor: 2.357

Review 2.  Advances in stress cardiac MRI and computed tomography.

Authors:  Yasmin S Hamirani; Christopher M Kramer
Journal:  Future Cardiol       Date:  2013-09

3.  Small, short-duration, dobutamine-induced perfusion defects are not associated with adverse prognosis in intermediate-risk individuals receiving cardiovascular magnetic resonance stress imaging.

Authors:  Jennifer H Jordan; Jason C Haag; Timothy M Morgan; Sujethra Vasu; Brandon Stacey; Craig Hamilton; Killian Robinson; Dalane Kitzman; Vinay Thohan; William Gregory Hundley
Journal:  J Comput Assist Tomogr       Date:  2014 May-Jun       Impact factor: 1.826

Review 4.  Assessment of myocardial ischemia with cardiovascular magnetic resonance.

Authors:  Bobak Heydari; Michael Jerosch-Herold; Raymond Y Kwong
Journal:  Prog Cardiovasc Dis       Date:  2011 Nov-Dec       Impact factor: 8.194

Review 5.  Pharmacological stress cardiovascular magnetic resonance.

Authors:  Runyawan Chotenimitkhun; W Gregory Hundley
Journal:  Postgrad Med       Date:  2011-05       Impact factor: 3.840

Review 6.  Multi-modal imaging of the pediatric heart transplant recipient.

Authors:  Jonathan H Soslow; Margaret M Samyn
Journal:  Transl Pediatr       Date:  2019-10

7.  Head-to-head comparison of first-pass MR perfusion imaging during adenosine and high-dose dobutamine/atropine stress.

Authors:  Robert Manka; Cosima Jahnke; Rolf Gebker; Bernhard Schnackenburg; Ingo Paetsch
Journal:  Int J Cardiovasc Imaging       Date:  2010-11-19       Impact factor: 2.357

8.  Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study.

Authors:  Valentina O Puntmann; Peter C Taylor; Andrew Barr; Bernhard Schnackenburg; Cosima Jahnke; Ingo Paetsch
Journal:  Rheumatology (Oxford)       Date:  2009-12-21       Impact factor: 7.580

9.  Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease.

Authors:  Eric L Wallace; Timothy M Morgan; Thomas F Walsh; Erica Dall'Armellina; William Ntim; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2009-03

Review 10.  Cardiac MRI assessment of myocardial perfusion.

Authors:  Yasmin S Hamirani; Christopher M Kramer
Journal:  Future Cardiol       Date:  2014-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.